Sable Therapeutics — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Sable Therapeutics is a private, early-stage biotech leveraging nanotechnology and scientific research to build beauty and personal care brands. Founded in 2020 and headquartered in San Diego, the company appears to be pre-revenue, focusing on translating biotech innovations into clinically validated consumer products. Its business model pivots from a traditional therapeutics developer to a hybrid 'biotech meets beauty' platform, aiming to establish a new category in body care. The company's current public-facing efforts are centered on brand creation and direct consumer engagement.

Nanotechnology

Technology Platform

Leverages biotechnology and nanotechnology research to develop clinically grounded formulations for beauty and body care products.

Opportunities

The company targets the high-growth cosmeceutical and clinical beauty market, where consumers increasingly demand products with scientifically-validated efficacy.

Its biotech heritage provides a strong foundation for creating differentiated, premium products in the underpenetrated body care category.

Risk Factors

Key risks include executing a hybrid biotech-consumer business model, intense competition in the beauty sector, dependence on external funding as a pre-revenue startup, and regulatory scrutiny over product claims.

Competitive Landscape

Sable competes in the premium beauty space against established clinical skincare brands, dermatologist-founded lines, and the science-forward divisions of large cosmetic conglomerates. Its differentiation relies on authentic biotech credentials and creating a new niche in advanced body care.

More companies in Drug Delivery & Formulation →More companies in United States →